Mike Hencke | Head, Investor Relations |
Christopher Viehbacher | CEO |
Michael McDonnell | Chief Financial Officer |
Priya Singhal | Interim Head, Research & Development |
Salveen Richter | Goldman Sachs |
Mohit Bansal | Wells Fargo |
Colin Bristow | UBS |
Umer Raffat | Evercore |
Evan Seigerman | BMO |
Tim Anderson | Wolfe Research |
Brian Abrahams | RBC Capital Markets |
Michael Yee | Jefferies |
Chris Schott | JPMorgan |
Good morning. My name is Bettina [ph], and I will be your conference operator today. At this time, I would like to welcome everyone to the Biogen Fourth Quarter and Full Year 2022 Earnings Call and Business Update. All lines have been placed on mute to prevent any background noise. After the speaker’s remarks, there’ll be a question-and-answer session.